Zobrazeno 1 - 10
of 102
pro vyhledávání: '"H. P. Kalofonos"'
Autor:
Thomas Makatsoris, Fotinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, M. Stavropoulos, Angelos Koutras, Anastasia E. Kottorou, H. P. Kalofonos
Publikováno v:
Annals of Oncology. 32:S175-S176
Autor:
Dimitrios Daoussis, Stamatis-Nick C. Liossis, H. P. Kalofonos, Alexandra Filippopoulou, Pantelis Kraniotis, Spyridoula Theodoraki, Aikaterini Solomou, Thomas Makatsoris, Angelos Koutras, Rafaella Argiriadi
Publikováno v:
Oral Presentations.
Background Immune check point inhibitors (ICI) were a breakthrough in cancer therapeutics. These agents target certain “brakes” of the immune system aiming at activating T cells to fight cancer. Taking into account their mechanism of action it is
Autor:
N. Kapodistrias, D. Mavroudis, V. Barbounis, P. Papakotoulas, Alexandros Ardavanis, Athina Christopoulou, Anna Koumarianou, Athanasios Athanasiadis, Alexandros Bokas, I. Boukovinas, Georgios Samelis, Epaminontas Samantas, Christos N. Papandreou, Nikolaos K. Kentepozidis, Ilias Athanasiadis, C. Andreadis, H. P. Kalofonos, Stavros D. Peroukidis, Nikolaos Tsoukalas, A. Ligdas
Publikováno v:
Annals of Oncology. 31:S1052
Autor:
Jordi Bruna, J. M. Piulats, M Alemany, Ernest Nadal, G G Anastopoulou, Roser Velasco, Marta Simó, H. P. Kalofonos, Andreas A. Argyriou
Publikováno v:
Neuro Oncol
BACKGROUND To explore the incidence and clinical phenotype of serious neurological adverse events (NAEs) in cancer patients who received immunotherapy with checkpoint inhibitors (ICIs) at two institutions. MATERIAL AND METHODS We reviewed files of ca
Autor:
Nikolaos Panagopoulos, D. Dougenis, Fotinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Angelos Koutras, Vasiliki Tzelepi, H. P. Kalofonos, Melpomeni Kalofonou, Anastasia E. Kottorou, Thomas Makatsoris
Publikováno v:
Annals of Oncology. 30:ii12
Autor:
D. Skarlos, D.G. Pectasides, Papadimitriou Ca, G. Fountzilas, Epaminontas Samantas, Flora Zagouri, Helen P. Kourea, Angelos Koutras, Kotoula, P. Kosmidis, Dimitrios Dionysopoulos, Kyriaki Papadopoulou, H. P. Kalofonos
Publikováno v:
The Pharmacogenomics Journal. 14:248-255
The aim of the study was to evaluate the association of vascular endothelial growth factor (VEGF) genotypes with treatment efficacy in a phase II trial. This study evaluated weekly docetaxel, as first-line treatment for metastatic breast cancer. Exis
Autor:
Vassiliki Zolota, V. Panagiotopoulos, Zinovia Kefalopoulou, Andreas A. Argyriou, H. P. Kalofonos, Chaido Sirinian, P. Spinos
Publikováno v:
Acta Neurologica Scandinavica. 129:226-233
Objective We examined the activation of the mitogen-activated protein kinases (MAPKs) signaling pathway in a cohort of brain gliomas, by taking advantage of a series of phosphorylation state-specific antibodies against phospho-p44/42(ERK1/2), phospho
Autor:
Diego Cortinovis, Roser Velasco, Sara Lonardi, Paola Alberti, Cristina Santos, Andreas A. Argyriou, Chiara Briani, Marina Cazzaniga, H. P. Kalofonos, Jordi Bruna, Guido Cavaletti, Mario Cacciavillani
Publikováno v:
Annals of Oncology. 23:3116-3122
Background To report our prospective experience on the incidence and pattern of oxaliplatin (OXA)-induced peripheral neuropathy (OXA-IPN) in patients with colorectal cancer (CRC) treated with either FOLFOX-4 or XELoda + OXaliplatin (XELOX). Patients
Autor:
Evangelos Bournakis, George Fountzilas, Anna Koumarianou, Eleni Galani, H. P. Kalofonos, Anastasia G Eleftheraki, Angelos Koutras, F.I. Dimitrakopoulos, Anna G. Antonacopoulou, Dimitris Bafaloukos, E. Briasoulis, Florentia Fostira, Iliada Bompolaki, Konstantine T. Kalogeras, D.G. Pectasides, Ioannis Varthalitis, Joseph Sgouros
Publikováno v:
The Pharmacogenomics Journal. 12:468-475
The aim of the study was to evaluate the association of vascular endothelial growth factor (VEGF) genotypes with treatment efficacy in a randomized trial. This study compared two chemotherapy regimens (FOLFIRI versus XELIRI) combined with bevacizumab
Autor:
Robert E. Hawkins, Yulia Hirschberg, Qasim Ahmad, Chaitali Babanrao Pisal, C. Suarez Rodriguez, Petri Bono, Luca Dezzani, Á. Rodríguez Sánchez, Aristotle Bamias, Eric Jonasch, Narayanan Srihari, Saulo A. Vázquez, Manuela Schmidinger, Giuseppe Procopio, H. P. Kalofonos
Publikováno v:
Annals of Oncology. 29:viii313